STAT

Congress isn’t acting to curb drug prices, so states are stepping up. Here’s how

With little action in Congress, states from California to Vermont are experimenting with ways to try to curb drug prices or shine a light on rising costs.

President Trump has complained that drug makers are getting away with murder — and he may be right.

Despite vociferous complaints from consumers that drug prices are too high, Congress has failed to act. And with few exceptions, the pharmaceutical industry has successfully delayed or thwarted state bills that would force drug makers to explain or justify price hikes.

But that may be starting to change. Last week, of the pharma industry, already has a similar policy in place.  recently began requiring drug makers to disclose pricing data about diabetes medicines. And has a new law that penalizes generic companies for price gouging.

You're reading a preview, sign up to read more.

More from STAT

STAT2 min read
Pelosi: Democrats Will Name Marquee Drug Pricing Bill For Late Rep. Cummings
Rep. Elijah Cummings, a longtime advocate for lower drug prices, passed away Thursday. Now Nancy Pelosi is naming Democrats’ drug pricing bill in his honor.
STAT4 min readSociety
An ‘Unprecedented’ Analysis Underlines Profound Failure To Study African Genomes
It has become the geneticist’s version of, “What, me not inclusive? But I have a black friend!” In the case of modern studies of DNA, researchers called to task for studying mainly European populations often defend themselves by pointing out that the
STAT3 min read
Opinion: CBO Estimate On Pelosi Drug Bill Misses Its Long-term Impact On Health
The CBO estimate on Speaker Nancy Pelosi's drug pricing bill misses its long-term impact on health.